Table 9.
Dynamics of wound size changes in the animals with the wounds infected with P. aeruginosa (М ± m).
| Subgroups | Parameter | Day 3 | Day 10 | Day 14 |
|---|---|---|---|---|
| n = 10 | n = 7 | n = 4 | ||
| Placebo | Wound square (cm2) | 6.33 ± 0.7 | 5.09 ± 0.44 | 2.63 ± 0.2 |
| Wound reduction (%) | 19.56 | 58.40 | ||
| Residual wound square (%) | 72.67 | 46.42 | ||
| Control | Wound square (cm2) | 4.86 ± 0.49 | 2.84 ± 0.46 * | 1.17 ± 0.06 * |
| Wound reduction (%) | 41.49 | 75.91 | ||
| Residual wound square (%) | 54.35 | 32.99 | ||
| Resveratrol | Wound square (cm2) | 5.61 ± 0.38 | 3.72 ± 0.7 | 1.41 ± 0.4 |
| Wound reduction (%) | 33.59 | 74.93 | ||
| Residual wound square (%) | 60.80 | 28.03 | ||
| Dihydroquercetin | Wound square (cm2) | 6.73 ± 0.45 | 4.10 ± 0.24 # | 1.86 ± 0.37 # |
| Wound reduction (%) | 39.13 | 72.44 | ||
| Residual wound square (%) | 65.84 | 36.33 | ||
| Dihydromyricetin | Wound square (cm2) | 5.81 ± 0.45 | 3.37 ± 0.38 * | 1.63 ± 0.3 |
| Wound reduction (%) | 42.06 | 72.03 | ||
| Residual wound square (%) | 63.17 | 28.95 |
*—p < 0.05 if being compared to the placebo group, #—p < 0.05 if being compared to the control group.